Johnson & Johnson

J&J To Exit Spinoff Kenvue With Latest Stake Sale

Kenvue Cuts Annual Profit Forecast On Soft Demand For Cold, Flu Medicines

Kenvue cut the higher end of its annual profit forecast, as the Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impac...

J&J Starts Share Exchange Offer For Consumer Health Spin-Off Kenvue

Johnson & Johnson has announced the launch of an exchange offer under which its stockholders can opt for shares of Kenvue, its newly lis...

J&J Spinoff Kenvue Forecasts Upbeat Annual Profit On Self-Care Boost

Consumer health firm Kenvue forecast full-year profit above Wall Street estimates, betting on resilient demand for its skincare and self-care products, suc...

Countdown To The Consumer Goods Forum Global Summit 2023

The Consumer Goods Forum Global Summit takes place in Kyoto, Japan, from 6 to 8 June 2023, with a call for retailers and consumer goods firms to come toget...

J&J Expects Inflation, China COVID-19 Hit To Carry Into 2023

Johnson & Johnson said it sees the impact from high inflation carrying into 2023 and expects China's major COVID-19 outbreak to dent sales at its medic...

J&J CEO Duato To Take Additional Role Of Chairman

Johnson & Johnson has announced that its board has elected chief executive officer Joaquin Duato to take on the additional role of chairman, effective...

J&J Unveils Name Of Consumer Health Business Ahead Of Spin-Off

Johnson & Johnson has named its consumer business Kenvue as it is moving ahead with its plans to spin-off the unit in what would be the biggest sha...